Stocktoria
Walvax Biotechnology Co., Ltd. 300142.SZ
Walvax Biotechnology Co., Ltd. statistics & valuation
Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value (CN¥3.67); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
Walvax Biotechnology Co., Ltd. trades at about 119.5× earnings — near its 10-year norm (10-year range 63×–125.5×, median 113.7×).
Shaded band = 10-year range (63×–125.5×); dot = today's 119.5×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | 74.6% | 79.7% | 85.5% | 88.0% |
| Operating margin | 14.1% | 10.3% | 24.9% | 26.2% |
| Net margin | 7.4% | 5.0% | 10.2% | 14.3% |
| FCF margin | -0.8% | 17.2% | 4.6% | 2.2% |
| Return on assets | 1.5% | 1.0% | 2.7% | 4.8% |
| Return on equity | 2.1% | 1.5% | 4.5% | 8.0% |
| Debt / equity | 0.02× | 0.05× | 0.05× | 0.03× |
| Current ratio | 2.35 | 2.98 | 2.73 | 2.55 |
Computed from company filings · CN · as of 2025-12-31. Figures in CNY. Facts plus Stocktoria's own computed scores — not investment advice.